Table 3.
Analyses testing potential differences in the base-case scenarios.
| Scenario |
rECG cost |
rECG QALY |
spECG cost |
spECG QALY |
ICER for spECG vs. rECG |
|---|---|---|---|---|---|
| Base case | 65,497 | 7.232 | 65,048 | 7.240 | Dominant |
| SSI rate: 2.5% after 90 days | 64,543 | 7.249 | 64,339 | 7.253 | Dominant |
| DSWI accounts for 0% of SSIs | 64,580 | 7.244 | 64,367 | 7.249 | Dominant |
| SSI: 2.5% and no DSWI | 64,124 | 7.255 | 64,028 | 7.257 | Dominant |
| 2% of CABG patients require pMV | 65,034 | 7.235 | 64,588 | 7.243 | Dominant |
| Population: age 60 and 10% diabetes | 75,982 | 10.167 | 75,567 | 10.175 | Dominant |
| rECG at $4 per use | 65,030 | 7.235 | 64,588 | 7.243 | Dominant |
| spECG at $30 per use | 65,034 | 7.235 | 64,618 | 7.243 | Dominant |
CABG, Coronary artery bypass graft; Dominant, Lower cost and higher QALYs; DSWI, Deep sternal wound infection; ECG, Electrocardiogram; pMV, Prolonged mechanical ventilation; QALY, Quality-adjusted life years; rECG, Reusable ECG; spECG, Single-patient-use ECG; SSI, Surgical site infection; vs, versus.